333 related articles for article (PubMed ID: 11882044)
21. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
[TBL] [Abstract][Full Text] [Related]
22. CD8+CD28- T cells in vertically HIV-infected children.
Brugnoni D; Airo P; Timpano S; Malacarne F; Ugazio AG; Cattaneo R; Duse M
Clin Exp Immunol; 1997 Sep; 109(3):412-5. PubMed ID: 9328114
[TBL] [Abstract][Full Text] [Related]
23. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
[TBL] [Abstract][Full Text] [Related]
24. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
[TBL] [Abstract][Full Text] [Related]
25. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
[TBL] [Abstract][Full Text] [Related]
26. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
Lim A; French MA; Price P
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
[TBL] [Abstract][Full Text] [Related]
27. Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes.
Zaunders J; Carr A; McNally L; Penny R; Cooper DA
AIDS; 1995 Jun; 9(6):561-6. PubMed ID: 7662193
[TBL] [Abstract][Full Text] [Related]
28. Fuzhengpaidu granule regulates immune activation molecules CD38 and human leukocyte antigen-D related on CD4+ and CD8+ T cells in patients with acquired immunodeficiency syndrome/human immunodeficiency virus.
Jiang F; Zhang R; Gu Z; Zhang H; Guo H; Deng X; Liang J
J Tradit Chin Med; 2013 Aug; 33(4):439-43. PubMed ID: 24187862
[TBL] [Abstract][Full Text] [Related]
29. Differences in peripheral blood lymphocyte phenotypes between Helicobacter pylori-positive children and adults with duodenal ulcer.
Figueiredo Soares T; Aguiar Rocha G; Camargos Rocha AM; Corrêa-Oliveira R; Martins-Filho OA; Teles Carvalho AS; Souto Bittencourt PF; Afonso Oliveira C; Ferreira Nogueira AM; Alvares Cabral MM; Caetano Faria AM; Queiroz DM
Clin Microbiol Infect; 2007 Nov; 13(11):1083-8. PubMed ID: 17727687
[TBL] [Abstract][Full Text] [Related]
30. CD4 and CD8 distribution profile in individuals infected by Schistosoma mansoni.
Oliveira-Prado R; Caldas IR; Teixeira-Carvalho A; Andrade MV; Gazzinelli A; Correa-Oliveira R; Cunha-Melo JR
Scand J Immunol; 2009 Jun; 69(6):521-8. PubMed ID: 19439013
[TBL] [Abstract][Full Text] [Related]
31. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of refined lymphocyte subsets changes in people living with HIV/AIDS during antiretroviral therapy period: An observation from Wuhan, China.
Yuan R; Li L; Hu W; Zhuang K; Zhang E; Yan Y; Feng L; Chen X; Cao Q; Ke H; Gui X; Yang R
Front Immunol; 2023; 14():1089379. PubMed ID: 36845097
[TBL] [Abstract][Full Text] [Related]
33. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
[TBL] [Abstract][Full Text] [Related]
34. Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men.
Margolick JB; Farzadegan H; Hoover DR; Saah AJ
J Infect Dis; 1996 Feb; 173(2):468-71. PubMed ID: 8568314
[TBL] [Abstract][Full Text] [Related]
35. Immune activation and CD127 expression on T lymphocyte subsets of a Chinese cohort of pediatric AIDS patients with different viral responses.
Jin C; Zhang F; Wu L; Xie T; Cheng Y; Tang Z; Wu N
Curr HIV Res; 2012 Oct; 10(7):584-91. PubMed ID: 22873638
[TBL] [Abstract][Full Text] [Related]
36. CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.
Tassiopoulos K; Landay A; Collier AC; Connick E; Deeks SG; Hunt P; Lewis DE; Wilson C; Bosch R
J Infect Dis; 2012 Jun; 205(11):1730-8. PubMed ID: 22448010
[TBL] [Abstract][Full Text] [Related]
37. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.
Köchli C; Wendland T; Frutig K; Grunow R; Merlin S; Pichler WJ
Immunol Lett; 1999 Feb; 65(3):197-201. PubMed ID: 10065743
[TBL] [Abstract][Full Text] [Related]
38. HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells.
Lewis DE; Yang L; Luo W; Wang X; Rodgers JR
AIDS; 1999 Jun; 13(9):1029-33. PubMed ID: 10397532
[TBL] [Abstract][Full Text] [Related]
39. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations.
Brinchmann JE; Dobloug JH; Heger BH; Haaheim LL; Sannes M; Egeland T
J Infect Dis; 1994 Apr; 169(4):730-8. PubMed ID: 7907640
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
